Lung capacity peaks early, then begins a slow biological decline
Human lung function does not stay fixed across adult life. An international analysis of data from about 30,000 men and women found that lung function reaches its highest point in the early to mid-20s, with women typically peaking a few years earlier than men before a gradual decline begins. Judith Garcia-Aymerich, who led the work at the Barcelona Institute for Global Health, described this as part of biologically programmed ageing rather than a random deterioration.
The pattern has real clinical meaning. When peak lung capacity is stronger, the body appears to have more reserve against chronic respiratory disease later in life. When the decline accelerates, the consequences are broader than shortness of breath alone. Smoking, air pollution, and flare-ups of asthma can all speed the drop, compressing the respiratory reserve that many people depend on for decades.
A low reading at home is not automatically a diagnosis. It is a signal to look harder.
Why weakening lungs affect the rest of the body
The ageing lung changes structurally. Elastic tissue stiffens, the diaphragm and other respiratory muscles weaken, and the rib cage loses some of its ability to expand fully. As those components lose efficiency, the mechanics of breathing become less effective and symptoms such as breathlessness can emerge. In more advanced cases, the process contributes to chronic obstructive pulmonary disease, where airflow is persistently limited.
The impact reaches well beyond the chest. Reduced lung function has been associated with higher blood pressure, autoimmune disease, metabolic disorders, frailty, and cognitive decline. Dawn Bowdish, who studies ageing and immunity at McMaster University, points to the close relationship between the lungs, the circulation, and the immune system as a reason for this overlap. The lungs contain millions of immune cells that clear pollution particles, fight infection, and repair the injury caused by repeated stretching during breathing.
When those cells cannot keep up, inflammation rises. Persistent inflammation can promote pulmonary scarring, making the lungs stiffer and less able to move air. The same inflammatory burden may also alter the body’s response to respiratory infections, creating a cycle in which infection, tissue damage, and immune activation reinforce one another. This is one reason lung health can act as a window into whole-body ageing rather than a narrow measure of respiratory status.
A crude home test can estimate vital capacity
A simple do-it-yourself method can give a rough sense of vital lung capacity, also called forced vital capacity or FVC. The setup requires a large plastic bottle, water, a bucket or bathtub, and a length of rubber tubing. The bottle is marked in 200ml increments, filled, inverted underwater, and then emptied by blowing through the tube. The number of water-line marks expelled is multiplied by 200ml to estimate the volume of air blown out.
John Dickinson, who leads the exercise respiratory clinic at the University of Kent, says the test measures the volume of air a person can breathe out. He notes that the concept of vital capacity dates back to the 1840s, when English surgeon John Hutchinson linked smaller breath volumes with shorter survival. Modern interpretation is more cautious, but the physiological idea remains sound: less exhaled air often reflects reduced respiratory reserve.
Home testing has clear limits. Many people cannot empty their lungs completely, which can produce falsely low readings. Even so, the test may prompt people to think more seriously about their breathing patterns and whether formal testing is needed.
Spirometry gives a more accurate clinical picture
For medical assessment, spirometry remains the standard tool. It measures both the volume and the speed of exhaled air and provides more reliable values for FVC, FEV1, and the FEV1/FVC ratio. Together, those numbers help clinicians distinguish normal variation from airflow obstruction and identify conditions that may be silently limiting breathing efficiency.
Dickinson recommends formal lung function testing about every 10 years for people without symptoms, and sooner if abnormal breathlessness appears. The distinction matters in everyday practice because respiratory decline can be gradual. A person may adapt to reduced capacity without realizing how much function has been lost until exercise tolerance, sleep, or recovery from infection begins to slip.
A single symptom is often the first clue. A spirometry trace tells the rest of the story.
Exercise, diet, and breathing muscle training can support lung health
Age-related decline cannot be stopped completely, but several interventions can help slow the rate of loss. Regular exercise can reduce airway inflammation and improve the strength and endurance of the muscles involved in breathing. Dietary changes may also help: lower salt intake has been linked with less lung inflammation and fibrosis in experimental research, while diets richer in fish oils, antioxidants, and vitamins C and E may help protect lung tissue from oxidative damage.
Quitting smoking and avoiding vaping remain essential. Both expose the airways to chemicals that can intensify inflammation and damage fragile tissue. Body weight also matters. Excess abdominal fat can physically restrict the lungs from expanding fully, reducing the amount of air that can be taken in with each breath.
Inspiratory muscle training, or IMT, offers another option. The method uses a resistance device to strengthen the diaphragm and intercostal muscles, much like resistance training strengthens the limbs. Studies have shown improvements in respiratory muscle strength, exercise capacity, and blood pressure. In practical use, two 30-breath sessions a day are often enough to produce benefit. Devices such as Powerbreathe have been used in hospitals for prehabilitation before surgery, in support of people recovering from Covid, and in selected patients with pulmonary fibrosis or prolonged ventilator dependence.
Singing and wind instruments may also train the breathing muscles. Mette Kaasgaard, a classical singer and assistant professor at the University of Southern Denmark, has worked on trials examining singing in people with COPD. She does not claim that singing reverses established lung damage. The plausible benefit lies elsewhere: longer phrases demand control of the diaphragm, the intercostal muscles, and the abdominal wall, which may improve the way those structures are recruited during daily breathing.
For ageing lungs, the goal is not perfection. It is preserving enough reserve to keep oxygen delivery and carbon dioxide removal efficient for as long as possible. When lung function drops faster than expected, the consequences can reach the heart, the immune system, and the brain before the problem is ever named at the bedside.